nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Syncope—Triamcinolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Cefpodoxime—Vertigo—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Cefpodoxime—Syncope—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Cefpodoxime—Dysuria—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Cefpodoxime—Neutropenia—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Cefpodoxime—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Cefpodoxime—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Cefpodoxime—Shock—Prednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Cefpodoxime—Cough—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Cefpodoxime—Convulsion—Triamcinolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Cefpodoxime—Convulsion—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Cefpodoxime—Hypertension—Triamcinolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Cefpodoxime—Hypertension—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Cefpodoxime—Myalgia—Triamcinolone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Cefpodoxime—Pneumonia—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Cefpodoxime—Myalgia—Methylprednisolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Cefpodoxime—Anxiety—Methylprednisolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Discomfort—Triamcinolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Discomfort—Methylprednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Dry mouth—Triamcinolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Cefpodoxime—Renal failure—Methotrexate—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Cefpodoxime—Stomatitis—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Cefpodoxime—Confusional state—Methylprednisolone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Cefpodoxime—Malaise—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Malaise—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Cefpodoxime—Vertigo—Betamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefpodoxime—Vertigo—Dexamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefpodoxime—Syncope—Betamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefpodoxime—Syncope—Dexamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefpodoxime—Haematuria—Methotrexate—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Shock—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Insomnia—Prednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Alopecia—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Shock—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Epistaxis—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Paraesthesia—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Cefpodoxime—Convulsion—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Convulsion—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Hypertension—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Hypertension—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Cefpodoxime—Myalgia—Dexamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Myalgia—Betamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Anxiety—Dexamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Cefpodoxime—Anxiety—Betamethasone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Cefpodoxime—Discomfort—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Discomfort—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Haemoglobin—Methotrexate—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Hypotension—Methylprednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Pain—Prednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Haemorrhage—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Insomnia—Triamcinolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Insomnia—Methylprednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Paraesthesia—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Anaemia—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Shock—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Shock—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Agitation—Prednisone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Cefpodoxime—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Cefpodoxime—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Cefpodoxime—Malaise—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Vertigo—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Syncope—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Cefpodoxime—Tinnitus—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Anorexia—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Anorexia—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Urticaria—Prednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Fatigue—Triamcinolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Fatigue—Methylprednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Pain—Triamcinolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Loss of consciousness—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Hypotension—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Hypotension—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Convulsion—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Hypertension—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Chills—Methotrexate—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Myalgia—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Anxiety—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Alopecia—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Insomnia—Dexamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Insomnia—Betamethasone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Paraesthesia—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Discomfort—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Dyspepsia—Betamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Cefpodoxime—Urticaria—Triamcinolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Urticaria—Methylprednisolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Dysgeusia—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Cefpodoxime—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Cefpodoxime—Decreased appetite—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Cefpodoxime—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Back pain—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Fatigue—Betamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Fatigue—Dexamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Shock—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Pain—Betamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Pain—Dexamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Cefpodoxime—Anorexia—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Anaemia—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Cefpodoxime—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Cefpodoxime—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Malaise—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Cefpodoxime—Vertigo—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Leukopenia—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Cefpodoxime—Urticaria—Betamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Urticaria—Dexamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Dizziness—Prednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Asthenia—Triamcinolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Body temperature increased—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Abdominal pain—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Asthenia—Methylprednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Insomnia—Prednisone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Paraesthesia—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Pruritus—Triamcinolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Cough—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Pruritus—Methylprednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Convulsion—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Cefpodoxime—Dyspepsia—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Chest pain—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Myalgia—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Cefpodoxime—Decreased appetite—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Rash—Prednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Dermatitis—Prednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Cefpodoxime—Fatigue—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Headache—Prednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Discomfort—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Constipation—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Confusional state—Methotrexate—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Cefpodoxime—Dizziness—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Dizziness—Methylprednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Cefpodoxime—Feeling abnormal—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Asthenia—Dexamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Asthenia—Betamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Nausea—Prednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Pruritus—Betamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Pruritus—Dexamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Vomiting—Triamcinolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Vomiting—Methylprednisolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Cefpodoxime—Rash—Triamcinolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Dermatitis—Triamcinolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Anorexia—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Rash—Methylprednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Urticaria—Prednisone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Cefpodoxime—Headache—Triamcinolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Headache—Methylprednisolone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Abdominal pain—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Body temperature increased—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Diarrhoea—Betamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Cefpodoxime—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Cefpodoxime—Hypotension—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Cefpodoxime—Dizziness—Dexamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Cefpodoxime—Dizziness—Betamethasone—psoriatic arthritis	0.001	0.001	CcSEcCtD
Cefpodoxime—Insomnia—Methotrexate—psoriatic arthritis	0.000995	0.000995	CcSEcCtD
Cefpodoxime—Nausea—Triamcinolone—psoriatic arthritis	0.00099	0.00099	CcSEcCtD
Cefpodoxime—Paraesthesia—Methotrexate—psoriatic arthritis	0.000988	0.000988	CcSEcCtD
Cefpodoxime—Nausea—Methylprednisolone—psoriatic arthritis	0.000987	0.000987	CcSEcCtD
Cefpodoxime—Dyspnoea—Methotrexate—psoriatic arthritis	0.000981	0.000981	CcSEcCtD
Cefpodoxime—Somnolence—Methotrexate—psoriatic arthritis	0.000978	0.000978	CcSEcCtD
Cefpodoxime—Hypersensitivity—Prednisone—psoriatic arthritis	0.00097	0.00097	CcSEcCtD
Cefpodoxime—Dyspepsia—Methotrexate—psoriatic arthritis	0.000968	0.000968	CcSEcCtD
Cefpodoxime—Vomiting—Betamethasone—psoriatic arthritis	0.000961	0.000961	CcSEcCtD
Cefpodoxime—Vomiting—Dexamethasone—psoriatic arthritis	0.000961	0.000961	CcSEcCtD
Cefpodoxime—Decreased appetite—Methotrexate—psoriatic arthritis	0.000956	0.000956	CcSEcCtD
Cefpodoxime—Rash—Dexamethasone—psoriatic arthritis	0.000953	0.000953	CcSEcCtD
Cefpodoxime—Rash—Betamethasone—psoriatic arthritis	0.000953	0.000953	CcSEcCtD
Cefpodoxime—Dermatitis—Betamethasone—psoriatic arthritis	0.000952	0.000952	CcSEcCtD
Cefpodoxime—Dermatitis—Dexamethasone—psoriatic arthritis	0.000952	0.000952	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00095	0.00095	CcSEcCtD
Cefpodoxime—Fatigue—Methotrexate—psoriatic arthritis	0.000948	0.000948	CcSEcCtD
Cefpodoxime—Headache—Dexamethasone—psoriatic arthritis	0.000947	0.000947	CcSEcCtD
Cefpodoxime—Headache—Betamethasone—psoriatic arthritis	0.000947	0.000947	CcSEcCtD
Cefpodoxime—Asthenia—Prednisone—psoriatic arthritis	0.000944	0.000944	CcSEcCtD
Cefpodoxime—Pain—Methotrexate—psoriatic arthritis	0.000941	0.000941	CcSEcCtD
Cefpodoxime—Pruritus—Prednisone—psoriatic arthritis	0.000931	0.000931	CcSEcCtD
Cefpodoxime—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000907	0.000907	CcSEcCtD
Cefpodoxime—Diarrhoea—Prednisone—psoriatic arthritis	0.000901	0.000901	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.0009	0.0009	CcSEcCtD
Cefpodoxime—Nausea—Betamethasone—psoriatic arthritis	0.000898	0.000898	CcSEcCtD
Cefpodoxime—Nausea—Dexamethasone—psoriatic arthritis	0.000898	0.000898	CcSEcCtD
Cefpodoxime—Urticaria—Methotrexate—psoriatic arthritis	0.000874	0.000874	CcSEcCtD
Cefpodoxime—Dizziness—Prednisone—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Cefpodoxime—Abdominal pain—Methotrexate—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Cefpodoxime—Body temperature increased—Methotrexate—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Cefpodoxime—Vomiting—Prednisone—psoriatic arthritis	0.000837	0.000837	CcSEcCtD
Cefpodoxime—Rash—Prednisone—psoriatic arthritis	0.00083	0.00083	CcSEcCtD
Cefpodoxime—Dermatitis—Prednisone—psoriatic arthritis	0.000829	0.000829	CcSEcCtD
Cefpodoxime—Headache—Prednisone—psoriatic arthritis	0.000825	0.000825	CcSEcCtD
Cefpodoxime—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000811	0.000811	CcSEcCtD
Cefpodoxime—Asthenia—Methotrexate—psoriatic arthritis	0.000789	0.000789	CcSEcCtD
Cefpodoxime—Nausea—Prednisone—psoriatic arthritis	0.000782	0.000782	CcSEcCtD
Cefpodoxime—Pruritus—Methotrexate—psoriatic arthritis	0.000778	0.000778	CcSEcCtD
Cefpodoxime—Diarrhoea—Methotrexate—psoriatic arthritis	0.000753	0.000753	CcSEcCtD
Cefpodoxime—Dizziness—Methotrexate—psoriatic arthritis	0.000727	0.000727	CcSEcCtD
Cefpodoxime—Vomiting—Methotrexate—psoriatic arthritis	0.000699	0.000699	CcSEcCtD
Cefpodoxime—Rash—Methotrexate—psoriatic arthritis	0.000694	0.000694	CcSEcCtD
Cefpodoxime—Dermatitis—Methotrexate—psoriatic arthritis	0.000693	0.000693	CcSEcCtD
Cefpodoxime—Headache—Methotrexate—psoriatic arthritis	0.000689	0.000689	CcSEcCtD
Cefpodoxime—Nausea—Methotrexate—psoriatic arthritis	0.000653	0.000653	CcSEcCtD
